Sanofi
JEVTANA
Manufacturer:
Sanofi
Name:
JEVTANA
HCPCS Code Descriptor:
Injection, cabazitaxel, 1 mg
Category:
J Code
HCPCS:
J9043
NDC(s):
00024-5824-11
Primary Type:
Oncology
Generic/Specialty Status:
Single-Source
Route of Administration:
Intravenous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
JEVTANA is an Oncology drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J9043 is aligned to the drug JEVTANA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/12
HCPCS Effective Date:
1/1/12
HCPCS Short Description:
Cabazitaxel injection
Billing and Coding Guide:
https://www.sanoficareassist.com/pdfs/jevtana-billing-coding-guide.pdf
Patient Assistance:
https://www.sanoficareassist.com/
